Last reviewed · How we verify

NCT07537998

Antegrade Intestinal Fluid Reinfusion for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a Single-Center, Prospective Randomized Controlled Trial.

Recruiting now Phase 2, PHASE3 Last updated 17 April 2026
What this trial tests

Phase 2, PHASE3 trial testing intestinal fluid infusion in Low Anterior Resection Syndrome in 160 participants. Currently enrolling.

Timeline
10 April 2026
Primary endpoint
10 April 2027
10 April 2028

Quick facts

Lead sponsorPei-Rong Ding
PhasePhase 2, PHASE3
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment160
Start date10 April 2026
Primary completion10 April 2027
Estimated completion10 April 2028
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Pei-Rong Ding — full company profile →

Who can join

Adults 18 to 75, any sex, with Low Anterior Resection Syndrome or Rectal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to learn if antegrade intestinal fluid reinfusion works to prevent low anterior resection syndrome (LARS) in patients with prophylactic ileal stoma. The main questions it aims to answer are: 1. Does it work to prevent LARS by antegrade intestinal fluid reinfusion before performing the ileostomy reversal surgery? 2. Is antegrade intestinal fluid reinfusion more effective than water infusion in preventing LARS. Participants will: 1. Receive either antegrade intestinal fluid reinfusion or antegrade water infusion through ileal stoma based on the standard of care at 1 month after anterior rectal resection, until the ileostomy reversal. 2. Keep a diary of their symptoms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Low Anterior Resection Syndrome

Currently open trials in the same condition.

Other Pei-Rong Ding trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07537998.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing